JO
SANA icon

John Overdeck’s Sana Biotechnology SANA Stock Holding History

John Overdeck’s Portfolio SANA Stock Details SANA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.23M Sell
638,837
-559,742
-47% -$1.8M ﹤0.01% 2904
2026
Q1 		$3.45M Sell
1,198,579
-381,126
-24% -$1.5M ﹤0.01% 2318
2025
Q4 		$6.43M Buy
1,579,705
+969,577
+159% +$4.34M 0.01% 1482
2025
Q3 		$2.17M Sell
610,128
-1,663
-0.3% -$6.01K ﹤0.01% 2073
2025
Q2 		$1.67M Buy
611,791
+504,305
+469% +$1.04M ﹤0.01% 1949
2025
Q1 		$181K Sell
107,486
-372,812
-78% -$1.04M ﹤0.01% 2872
2024
Q4 		$783K Buy
480,298
+334,042
+228% +$996K ﹤0.01% 2322
2024
Q3 		$608K Sell
146,256
-267,254
-65% -$1.4M ﹤0.01% 2370
2024
Q2 		$2.26M Buy
413,510
+323,710
+360% +$2.58M 0.01% 1474
2024
Q1 		$898K Buy
89,800
+15,042
+20% +$113K ﹤0.01% 2016
2023
Q4 		$305K Sell
74,758
-47,768
-39% -$176K ﹤0.01% 2691
2023
Q3 		$474K Sell
122,526
-140,931
-53% -$757K ﹤0.01% 2300
2023
Q2 		$1.57M Buy
263,457
+171,957
+188% +$991K ﹤0.01% 1650
2023
Q1 		$299K Buy
91,500
+50,146
+121% +$200K ﹤0.01% 2419
2022
Q4 		$163K Sell
41,354
-110,558
-73% -$541K ﹤0.01% 2431
2022
Q3 		$911K Buy
151,912
+94,163
+163% +$680K ﹤0.01% 1507
2022
Q2 		$371K Sell
57,749
-180,298
-76% -$1.15M ﹤0.01% 1936
2022
Q1 		$1.97M Buy
238,047
+158,786
+200% +$1.28M 0.01% 1357
2021
Q4 		$1.23M Buy
+79,261
New +$1.53M ﹤0.01% 2368

Other funds holding SANA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
MG
Marex Group London $23.6B AUM 57.16% 1-Year Est. Return

John Overdeck's SANA Position: Q2 2026 in Review

John Overdeck reduced its Sana Biotechnology (SANA) stake by 47% in Q2 2026, selling an estimated $1.8M and leaving 638,837 shares worth $2.23M. The position accounts for ﹤0.01% of the portfolio, ranked #2904.

John Overdeck first reported a position in SANA in Q4 2021 and has held it in 19 quarters since. The position peaked at $6.43M in Q4 2025. 208 funds tracked by Wall St. Rank hold SANA as of Q2 2026.

  • John Overdeck held 638,837 shares of Sana Biotechnology worth $2.23M as of Q2 2026.
  • John Overdeck sold 559,742 Sana Biotechnology shares in Q2 2026, an estimated $1.8M.
  • Sana Biotechnology made up ﹤0.01% of John Overdeck's portfolio in Q2 2026, its #2904 holding.
  • John Overdeck first reported a position in Sana Biotechnology in Q4 2021 and has held it in 19 quarters since.
  • John Overdeck's Sana Biotechnology position peaked at $6.43M in Q4 2025.
  • 208 funds tracked by Wall St. Rank held Sana Biotechnology as of Q2 2026.

Based on Two Sigma Investments's 13F filing for Q2 2026, filed 14 Aug 2026.